Approval · Notice of Compliance 9007 · 2007
ORZEL: Notice of Compliance 9007
Issued September 6, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9007
- Date
- September 6, 2007
- Company
- Emd Serono Canada Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic agnet and folic acid derivative
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORZEL | 02243681 | — |
Medicinal ingredients
- TEGAFUR 100 MG per CAP
- URACIL 224 MG per CAP
- LEUCOVORIN CALCIUM 15 MG per TAB